Understanding Your Celiac Blood Test Results
Blood tests are the first step in diagnosing celiac disease. If your doctor orders a celiac panel, you'll receive results that may include several different antibody tests — each measuring something slightly different. Understanding what these tests are, how to interpret your results, and what happens next helps you navigate the diagnostic process.
Why Celiac Testing Uses Antibodies
Celiac disease is an autoimmune condition in which the immune system generates antibodies against the body's own tissues (specifically, the enzyme tissue transglutaminase) and against components of gluten (gliadin peptides). These antibodies circulate in the blood and can be measured. Their presence, at levels above normal, indicates that the immune system is responding to gluten in the way characteristic of celiac disease.
Critically, these tests are only accurate if you're currently eating a regular gluten-containing diet. If you've already started a GF diet, the immune response quiets and antibody levels fall, leading to false-negative results.
The Main Celiac Blood Tests
1. Tissue Transglutaminase IgA (tTG-IgA) — The Primary Test
This is the most important and most accurate single celiac antibody test. Sensitivity is 95-98% and specificity is 94-97%.
- Positive result: A strong indicator of celiac disease — warrants intestinal biopsy for confirmation
- Negative result: Makes celiac disease unlikely (but not impossible, especially in IgA-deficient individuals)
- Results format: Usually reported as a ratio (e.g., >1:80), a number with a reference range, or simply positive/negative/equivocal
If tTG-IgA is very strongly positive (>10x the upper limit of normal), this correlates with more extensive intestinal damage and, in children, may allow diagnosis without biopsy under European guidelines.
2. Total IgA — Always Check Alongside tTG-IgA
About 1 in 500 people has IgA deficiency, a condition where the immune system produces little or no IgA antibodies. Since tTG-IgA and several other celiac tests measure IgA-class antibodies, IgA deficiency will cause false-negative results on all IgA-based tests.
- Normal total IgA: Your tTG-IgA and other IgA tests are reliable
- Low or absent total IgA (IgA deficiency): Your doctor should use IgG-based tests instead
3. Endomysial Antibody (EMA-IgA) — High Specificity
The EMA test is very specific — if it's positive, celiac disease is almost certain. Sensitivity is slightly lower than tTG-IgA (85-98%). It's often used to confirm a positive tTG-IgA result.
- Positive EMA + positive tTG-IgA: Very strong evidence of celiac disease
- Negative EMA + positive tTG-IgA: Could indicate early or mild celiac disease where EMA hasn't turned positive yet, or occasionally a false positive on tTG-IgA
4. Deamidated Gliadin Peptide IgA and IgG (DGP-IgA, DGP-IgG)
These tests detect antibodies to specific gliadin peptides. They're particularly useful:
- In children under 2, where tTG-IgA may be less reliable
- In individuals with IgA deficiency (using the IgG version)
- As additional confirmation when other tests are equivocal
5. Anti-Gliadin Antibodies (AGA) — Older Test, Less Useful
Older celiac panels included anti-gliadin antibodies. These are no longer recommended as a primary diagnostic tool because they have lower specificity and sensitivity than newer tests. A positive AGA alone does not diagnose celiac disease.
Reading Your Results: Common Scenarios
Scenario 1: tTG-IgA positive, EMA positive
This is the clearest positive result. Celiac disease is very likely. Intestinal biopsy should be scheduled promptly to confirm and assess the degree of damage.
Scenario 2: tTG-IgA positive, EMA negative
Moderately strong evidence for celiac disease, but less certainty. Biopsy is still indicated. The negative EMA may occur early in the disease or with mild damage.
Scenario 3: tTG-IgA borderline (slightly elevated), other tests negative
This is an equivocal or "gray zone" result. Possible explanations:
- Early celiac disease before full antibody development
- Celiac disease with low gluten intake at the time of testing
- A false positive (tTG-IgA can be mildly elevated in other autoimmune conditions like type 1 diabetes or Crohn's disease)
Your doctor may recommend:
- Repeating the test in 3-6 months while continuing to eat gluten
- Proceeding to biopsy anyway, especially with strong symptoms
- Genetic testing to assess risk
Scenario 4: All tests negative with active gluten consumption
Celiac disease is unlikely but not impossible. About 5% of celiac patients are "seronegative" (negative blood tests despite biopsy-confirmed celiac disease), usually due to IgA deficiency or very early/mild disease. If symptoms are strong, biopsy may still be indicated.
Scenario 5: All tests negative in someone already eating GF
The results are uninterpretable. You must re-introduce gluten for a period of time before testing can give accurate results. See your doctor about the appropriate gluten challenge protocol.
What Happens After a Positive Blood Test
A positive tTG-IgA is not a celiac diagnosis — it's an indication that celiac disease is likely and that further evaluation is needed. The standard next step is:
- Referral to a gastroenterologist for evaluation
- Upper endoscopy with intestinal biopsy to confirm villous atrophy and grade the severity
- Continue eating gluten until after the biopsy — stopping gluten before biopsy can cause the intestinal lining to begin healing and the biopsy may show less or no damage
- Baseline nutritional testing (iron, vitamin D, B12, folate, zinc)
- Normal: Antibody levels should fall toward the normal range within 6-12 months of strict GF adherence
- Persistent elevation: Suggests ongoing gluten exposure — either known diet adherence issues or hidden gluten sources
- Rising levels after normalization: Suggests a new source of gluten in the diet
Monitoring After Diagnosis and GF Diet
Once you've been diagnosed and have started a GF diet, tTG-IgA is used to monitor your response:
Most gastroenterologists recommend checking tTG-IgA at 6 months after diagnosis and annually thereafter.